Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion type Assertion NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_head.
- NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion description "[Stage-adjusted recurrence and death rates were nonsignificantly better for BRCA2 cases (hazard ratios of 0.84 and 0.59 [P =.61 and P =.19], respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_provenance.
- NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion evidence source_evidence_literature NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_provenance.
- NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion SIO_000772 10550133 NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_provenance.
- NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion wasDerivedFrom befree-20140225 NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_provenance.
- NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_assertion wasGeneratedBy ECO_0000203 NP881454.RAk6mEnpa1JCiKRiCJtDv6ULEYcaB976pWlfZeYVeH5Vk130_provenance.